Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Stockholders' Equity

v3.22.2
Note 12 - Stockholders' Equity
 6 Months Ended
Jun. 30, 2022
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

12. Stockholders’ Equity

 

Shares issued

 

During the six months ended June 30, 2022, the Company issued 1,105,011 shares of common stock upon vesting of Restricted Stock Units ("RSUs") granted by the Company to management and employees. 

 

During the six months ended June 30, 2022, the Company issued 34,118 shares of common stock upon vesting of RSUs granted to Board members.

 

During the six months ended June 30, 2022, the Company issued 4,217,134 shares of common stock pursuant to the At The Market Issuance Sales Agreement for net proceeds of $4.6 million.

 

Stock-based compensation

 

The stock-based compensation expense was allocated as follows:

 

   

Three Months Ended June 30,

    

Six Months Ended June 30,

  
   

2022

    

2021

    

2022

    

2021

  

Cost of product sales

   $ 23     $ 16     $ 48     $ 47  

Research and development cost

     18       11       36       53  

General and administrative expense

     493       592       1,055       1,198  

Total

   $ 534     $ 619     $ 1,139     $ 1,298  

 

There were no options issued during the three and six months ended June 30, 2022 or the three and six months ended June 30, 2021.

 

Restricted stock units

 

In January 2022, the Company granted 44,780 RSUs, all of which were subject to vesting, with a grant fair value of $50,000 to employees. The shares vest in three equal installments over a three-year period.

 

In February 2022, the Company granted 47,933 RSUs, all of which were subject to vesting, with a grant fair value of $50,000 to employees. The shares vest in three equal installments over a three-year period.

 

In April 2022, the Company granted 9,615 RSUs, all of which were subject to vesting, with a grant fair value of $10,000 to employees. The shares vest in three equal installments over a three-year period.

 

In May 2022, the Company granted 182,293 RSUs, all of which were subject to vesting, with a grant fair value of $175,000 to Board Members. The shares vest in four equal installments over a twelve-month period.

 

In June 2022, the Company granted 12,121 RSUs, all of which were subject to vesting, with a grant fair value of $10,000 to employees. The shares vest in three equal installments over a three-year period.